AHA Guidance for the Diagnosis and Management of Transthyretin Amyloid Cardiomyopathy
Scientific statement by the AHA provides up-to-date information and recommendations for the diagnosis and management of transthyretin amyloid cardiomyopathy.
General Cardiology
Rilonacept Reduces Risk for Recurrent Pericarditis Events in Phase 3 Trial
Kiniksa Pharmaceuticals announced positive data from the phase 3 RHAPSODY trial evaluating rilonacept for the treatment of recurrent pericarditis.
Inhibition of Sclerostin May Increase Cardiovascular Risk
Inhibition of sclerostin with romosozumab may increase cardiovascular risk, according to research published in the June 24 issue of Science Translational Medicine.
Subclinical Hypothyroidism in NAFLD Is Associated With All-Cause and Cardiovascular Mortality
Low thyroid function is associated with nonalcoholic fatty liver disease and predicted all-cause and cardiovascular mortality in this population.
AHA Statement on Managing Pregnant Women With CVD
The American Heart Association outlined several considerations for the management of pregnant women with CVD or CVD-related conditions.
Cardioprotective Therapy Use Lower With Cancer History
Cardioprotective therapies, especially statins and antiplatelets, are underutilized in patients with a history of cancer (CaHx).
CMR Criteria to Distinguish Patients With NCCM With Likely Pathogenic Variant
CMR criteria along with family history can determine those patients in whom a (likely) pathogenic variant for noncompaction cardiomyopathy can be identified.
Improved Algorithms Needed to Identify Intravenous Drug Use-Associated Endocarditis
A team of investigators reviewed data from institutions within the VA healthcare system to assess the ability of 2 algorithms to identify patients with intravenous drug use-associated infective endocarditis.
Midlife Blood Pressure During Exercise Predicts Later Heart Disease
Higher blood pressure (BP) during exercise and impaired BP recovery after exercise in midlife may be markers of subclinical and clinical cardiovascular disease and mortality in later life.
CVD, Non-CVD Mortality Increased With Azithromycin Use
Outpatient azithromycin use is associated with an increased risk for cardiovascular and noncardiovascular mortality.
-
Loading...
-
Loading...
Next post in General Cardiology
